Aerie Pharmaceuticals Enters Into Lease Agreement With IDA Ireland

Aerie Pharmaceuticals has entered into a lease agreement with IDA Ireland to set up a new manufacturing plant in the recently built 2,650m2 IDA Advanced Technology Building in Athlone, Ireland.

Aerie has commenced its design plan for the facility and expects to begin internal construction in early 2017.


The project is supported by the Department of Jobs, Enterprise & Innovation through IDA Ireland.

The Athlone facility will house Aerie's first manufacturing plant, which is expected to produce commercial supplies for Aerie's current product candidates, RhopressaTM and RoclatanTM. If approved, the products are expected to offer the first new mechanisms of action for treatment of patients with glaucoma in some 20 years.

(CD/LM)